Indications
Vitamin A generally includes fat-soluble compounds such as retinol, retinyl palmitate, and β-carotene. These metabolites of vitamin A are essential for vision, cellular differentiation, epithelial integrity, and immune function.[1]
Vitamin A is obtained from the following 2 dietary forms:
- Preformed vitamin A (retinol and retinyl ester) is derived from animal products such as meat, dairy, and fish.
- Provitamin A (β-carotene), which is obtained from colorful fruits and vegetables.
Both these ingested forms of vitamin A must be converted to retinal and retinoic acid after absorption to support various biological processes.[1]
Vitamin A deficiency leads to the replacement of normal epithelium with stratified, keratinizing epithelium in the eyes, periocular glands, respiratory tract, alimentary tract, and genitourinary tract.[2] In contrast, excessive vitamin A can cause both acute and chronic harmful effects on health. Vitamin A deficiency is much more prevalent worldwide than vitamin A toxicity. The World Health Organization (WHO) estimates that 3 million children develop clinical vitamin A deficiency annually, compared to approximately 200 cases of vitamin A toxicity diagnosed each year.[3]
Globally, vitamin A deficiency is a significant public health issue. Supplementation is a key intervention that significantly reduces child morbidity and mortality from preventable diseases in countries with high mortality rates among children aged 5 or younger. Vitamin A supplementation is considered one of the most cost-effective strategies to improve childhood survival rates.
In patients with vitamin A deficiency, vitamin A supplementation is used to treat measles. Vitamin A is used to treat xerophthalmia and severe malnutrition and to prevent deficiency in pregnant women living in areas where vitamin A deficiency is endemic. The treatment of xerophthalmia is particularly important, as it is one of the few diseases caused by a vitamin deficiency that has reached epidemic levels. The clinical response to vitamin A supplementation for xerophthalmia is well established and can prevent night blindness, a significant issue in developing countries.[4]
Previous studies have not provided sufficient evidence to indicate a strong correlation between vitamin A and cancer prevention across all populations. In vitamin A-sufficient populations, supplementation has not shown any added benefit for cancer prevention. However, in vitamin A-deficient populations, such as malnourished or tobacco-dependent individuals, supplementation may help reduce the incidence of cancer.[5] A meta-analysis found that individuals with tuberculosis had low levels of vitamins A and D, with vitamin D deficiency identified as a potential risk factor.[6]
The WHO grading system for eye signs of vitamin A deficiency in children categorizes the severity of xerophthalmia as follows:
- XN—Night blindness: Difficulty seeing in low-light conditions due to impaired retinal function from vitamin A deficiency.
- X1A—Conjunctival xerosis: Dryness and thickening of the conjunctiva, which are often the first signs of vitamin A deficiency.
- X1B—Bitot spots: Foamy, grayish lesions on the conjunctiva, which is indicative of advanced deficiency.
- X2—Corneal xerosis: Dryness of the cornea, which may lead to potential visual impairment if untreated.
- X3A—Corneal ulcer covering less than one-third of the cornea: A localized ulceration of the cornea, typically painful but reversible with intervention.
- X3B—Corneal ulcer covering at least one-third of the cornea (keratomalacia): A more extensive corneal ulcer that may lead to corneal softening and perforation, resulting in significant visual loss.
- XS—Corneal scarring: Permanent corneal scarring from severe vitamin A deficiency, leading to irreversible vision impairment.
FDA-Approved Indications
The US Food and Drug Administration (FDA) approves the parenteral formulation of vitamin A for managing vitamin A deficiency. This formulation is indicated when oral supplementation is not feasible, such as in patients with vomiting, preoperative or postoperative states, or malabsorption syndromes.[7][8]
Off-Label Uses
Parenteral vitamin A supplementation in infants with very low birth weight reduces the risk of bronchopulmonary dysplasia (BPD), although repeated injections may cause discomfort. Further research is needed to determine whether enteral supplementation of water-soluble vitamin A is equally safe and effective in reducing BPD severity in these infants.[9] Vitamin A deficiency has been linked to the dysfunction of helper T cells, which have a central role in the autoimmune response associated with type 1 diabetes (T1D). Additionally, some studies suggest decreased serum vitamin A levels in patients with type 1 diabetes.
Serum vitamin A levels appear to be reduced in patients with T1D, suggesting a potential role of vitamin A in T1D pathophysiology. Further research is needed to explore the mechanisms underlying this relationship and its clinical implications for T1D management.[10] Vitamin A deficiency, along with infectious diseases that transiently suppress serum retinol concentrations, impairs normal immune function. In particular, vitamin A deficiency is recognized as a risk factor for the measles virus, which is a significant cause of childhood morbidity and mortality. Megadoses of vitamin A (eg, 200,000 IU for 2 days) have been shown to reduce the incidence of measles-related deaths.[3] Additionally, according to the American Academy of Ophthalmology, vitamin A deficiency is a significant risk factor for dry eye disease.[11]
Mechanism of Action
Register For Free And Read The Full Article
Search engine and full access to all medical articles
10 free questions in your specialty
Free CME/CE Activities
Free daily question in your email
Save favorite articles to your dashboard
Emails offering discounts
Learn more about a Subscription to StatPearls Point-of-Care
Mechanism of Action
In the liver, retinol is esterified to retinyl esters and stored in stellate cells. In tissues, both retinol and β-carotene are oxidized to retinal and retinoic acid, which are critical for vision and gene regulation, respectively. These active metabolites bind to nuclear receptors of the RAR family to regulate gene expression.[1][12][13][14] Additionally, vitamin A is crucial in immune function by modulating various processes, including the development of helper T- and B cells, which are essential for adaptive immunity.
Vitamin A is essential for mucosal epithelial regeneration and supports the function of neutrophils, macrophages, and natural killer cells, making it crucial for innate immunity. This vitamin is also crucial in cell morphogenesis, differentiation, and proliferation, as well as for gene regulation. Furthermore, as an antioxidant, vitamin A helps reduce free radical damage to DNA. A deficiency in vitamin A is believed to contribute to neoplastic transformation and carcinogenesis.[5]
Pharmacokinetics
Absorption: Vitamin A is primarily absorbed in the gastrointestinal tract, where β-carotene is converted into retinol. This process depends on bile salts, pancreatic lipase, and dietary fat to facilitate proper absorption.
Distribution: After absorption, vitamin A is transported by chylomicrons through the lymphatic system into the bloodstream, where it is delivered to the liver and other tissues for storage and use. The liver stores approximately 70% of the body's total vitamin A reserves, while smaller amounts are stored in other organs and fat cells.[15]
Metabolism: The liver primarily stores vitamin A as retinol palmitate within Kupffer cells. Under normal conditions, these liver stores can supply the body's vitamin A needs for up to 2 years.
Elimination: Vitamin A is primarily excreted through bile into the intestines, with elimination occurring via feces. Small amounts of vitamin A and its metabolites are also excreted in urine.
Administration
Available Dosage Forms and Strengths
Vitamin A is available in various dosage forms and strengths, including capsules (7500 U, 8000 U, 10,000 U, and 25,000 U), tablets (10,000 U and 15,000 U), and injectable solutions of vitamin A palmitate (50,000 USP U/mL, equivalent to 15 mg retinol/mL).
Vitamin A supplementation can be administered orally or intramuscularly. As vitamin A is lipophilic, consuming it with a fatty meal enhances its absorption.[1]
Adult Dosage for Vitamin A Deficiency
- Initial dosage: Vitamin A is initially administered at 100,000 U daily for 3 days, followed by 50,000 U daily for 2 weeks.
- Follow-up therapy: An oral multivitamin containing 10,000 to 20,000 U of vitamin A daily for 2 months is recommended.
Specific Patient Populations
Hepatic impairment: The manufacturer's labeling does not provide dosage adjustment recommendations.
Renal impairment: The manufacturer's labeling does not provide dosage adjustment recommendations.
Pregnancy considerations: A reported case of a pregnant woman aged 36 who developed vitamin A toxicity from ingesting fish liver, resulting in a miscarriage, underscores the potential risks to pregnancy and the need for education about this danger for women of childbearing age.[16] According to product labeling, consuming more than 6000 U of vitamin A daily during pregnancy has not been established as safe, as this may lead to fetal harm, including malformations of the central nervous system, eyes, palate, and urogenital tract.[17] Vitamin A intake above the recommended dietary allowance is contraindicated in women who are pregnant or may become pregnant. Although vitamin A is essential for fetal development and ocular integrity, excessive intake—especially during the first 60 days of pregnancy—can have teratogenic effects.
In contrast, vitamin A deficiency continues to be a significant public health issue in developing countries, where supplementation is recommended to prevent maternal and infant morbidity, including night blindness. While routine prenatal vitamin A supplementation is not advised in developed countries, targeted supplementation is recommended in regions where vitamin A deficiency is prevalent.[18]
Breastfeeding considerations: Infants are born with limited vitamin A stores, even when the mother maintains adequate levels. Breast milk, particularly colostrum, provides a vital source of vitamin A, supporting the infant's liver stores and ensuring a sufficient supply during periods of low intake. The concentration of vitamin A in breast milk, primarily in the form of retinyl esters, varies significantly across regions, influenced by factors such as the presence of β-carotene, α-carotene, and β-cryptoxanthin.
The primary sources of vitamin A in breast milk are blood retinol and retinyl esters in chylomicrons, which are incorporated into milk after lipolysis. Although vitamin A requirements increase during lactation, limited data are available on the direct impact of breastfeeding on maternal vitamin A status, assuming that increased maternal needs align with the amount of vitamin A produced in milk.[19]
Pediatric patients: A systematic review of vitamin A supplementation has highlighted its significant impact in reducing morbidity and mortality in children aged between 6 months and 5 years, particularly those with vitamin A deficiency. The evidence supports the effectiveness of vitamin A supplementation in preventing conditions such as diarrhea, measles, and night blindness, emphasizing the crucial role of vitamin A in pediatric health.[20]
According to product labeling, parenteral vitamin A supplementation for the treatment of vitamin A deficiency in pediatric patients is recommended as follows:
- For children aged 1 to 8: A dosage of 17,500 to 35,000 U of vitamin A daily for 10 days is advised, which is followed by oral multivitamin supplementation containing 5000 to 10,000 U of vitamin A daily for 2 months.
- For infants: The recommended parenteral dosage is 7500 to 15,000 U daily for 10 days, with follow-up therapy consisting of oral multivitamin supplementation containing 5000 to 10,000 U of vitamin A daily for 2 months.
Vitamin A treatment for deficiency states is considered a crucial therapy in the pediatric population. The American Society for Parenteral and Enteral Nutrition has provided guidelines for supplementation in this group, as outlined in the 2024 Parenteral Nutrition Product Shortage Recommendations: Intravenous Multivitamins.
Older patients: The recommended vitamin A intake for individuals aged 51 and older is 900 mcg RAE (Retinol Activity Equivalents) for males and 700 mcg RAE for females.
Adverse Effects
Excessive levels of natural or synthetic vitamin A can lead to various adverse effects. Vitamin A toxicity, also known as hypervitaminosis A, is more commonly associated with the misuse of vitamin A supplements than with health intervention programs. Toxic reactions can also result from consuming liver products rich in vitamin A or from the overuse of vitamin A preparations. The amount of vitamin A required to cause toxicity varies among individuals, depending on factors such as age and hepatic function.
Vitamin A Toxicity
Acute vitamin A toxicity: This may occur with a single ingestion of 25,000 IU/kg or more of vitamin A. Symptoms include nausea, vomiting, diarrhea, dizziness, lethargy, drowsiness, increased intracranial pressure, and skin changes such as erythema, pruritus, or desquamation.
Chronic vitamin A toxicity: This may result from the excessive ingestion of 4000 IU/kg or more of vitamin A daily for 6 to 15 months. Signs and symptoms include low-grade fever, headache, fatigue, anorexia, intestinal disturbances, hepatosplenomegaly, anemia, hypercalcemia, subcutaneous swelling, nocturia, joint and bone pain, and skin changes such as yellowing, dryness, alopecia, and photosensitivity.
Vitamin A is highly teratogenic if administered during pregnancy. Retinoids affect the expression of the homeobox gene Hoxb-1, which regulates the axial patterning of the embryo. Birth abnormalities include craniofacial, cardiac, and central nervous system malformations. Therefore, treatment with vitamin A should be avoided in pregnant patients, except in areas where vitamin A deficiency is prevalent. In such cases, vitamin A supplementation should not exceed 10,000 IU daily.[21]
Vitamin A administration alongside immunization has been associated with mild adverse effects, including loose stools, headache, irritability, fever, nausea, and vomiting. These adverse effects are rare and typically resolve within 24 to 48 hours. For more information, please refer to the WHO's Vitamin A supplementation guide.
Drug-Drug Interactions
Orlistat: Orlistat reduces the absorption of dietary fats by inhibiting gastric and pancreatic lipases, which may also decrease the absorption of the fat-soluble vitamin A. Patients should be advised to take a vitamin A supplement at least 2 hours before or 2 hours after taking orlistat to ensure optimal absorption.[22]
Oral contraceptives: A study indicated significant interactions between oral contraceptive pill use and vitamin A, with women on oral contraceptive pills exhibiting elevated plasma vitamin A levels. Caution is recommended in these cases.[23]
Contraindications
Vitamin A is contraindicated in pregnant and breastfeeding patients, as well as those with hypersensitivity to this class of drugs. Caution should be exercised when prescribing vitamin A to patients with hepatic or renal disease, alcoholism, or acne vulgaris.[24]
Warning and Precautions
A meta-analysis suggests that high-dose vitamin A supplementation, particularly β-carotene, may be associated with an increased risk of lung cancer and cardiovascular mortality. This can also lead to adverse effects, such as hepatotoxicity. Further research and caution are advised.[25]
Additionally, vitamin A and its metabolites may be implicated in idiopathic intracranial hypertension, warranting further studies to explore this potential link.[26]
Monitoring
Serum retinol levels may not accurately represent liver retinyl ester levels. However, as they decrease when liver stores of vitamin A are depleted, serum retinol levels remain clinically helpful.[27]
Isotretinoin, an oral medication derived from vitamin A, is primarily used to treat severe acne. The package insert for this medication recommends baseline lipid and hepatic panels, followed by repeat testing weekly or biweekly until a response is established. However, a recent meta-analysis showed that increases in triglyceride or cholesterol levels typically occur within the first 8 weeks of therapy, with minimal to no change afterward. The data were insufficient to conclude an early rise in liver function tests, although elevated liver function values were rarely considered high risk. Based on these findings, the evidence from the meta-analysis does not support monthly laboratory testing for standard doses of oral isotretinoin.[28]
Toxicity
Signs and Symptoms of Overdose
Vitamin A toxicity may present with various clinical symptoms, including abdominal pain, headache, nausea, and facial flushing. Laboratory findings often include mild anemia, thrombocytopenia, elevated liver function tests, and a significant increase in serum retinol levels. Although the diagnosis is primarily clinical, laboratory tests such as serum retinol or retinyl ester levels can assist in confirming the diagnosis. A thorough dietary history is essential to identify excessive vitamin A intake.
Management of Overdose
Symptoms of toxicity may resolve within several weeks after discontinuing vitamin A and initiating supportive therapy. Patients with increased intracranial pressure may require lumbar punctures or medications such as mannitol and diuretics for management. Patients with hypercalcemia may need intravenous fluids and additional treatments, such as calcitonin and corticosteroids.[21] Vitamin A toxicity can present with a range of clinical features, including abdominal pain, headache, nausea, and facial flushing. Laboratory findings often show mild anemia, thrombocytopenia, elevated liver function tests, and a significant increase in serum retinol levels. Although the diagnosis is primarily clinical, laboratory tests such as serum retinol or retinyl ester levels can help confirm the condition.
A dietary history is crucial to identify excessive vitamin A intake, which can lead to these symptoms. Managing vitamin A toxicity involves the immediate cessation of vitamin A intake, which typically results in symptom improvement and normalization of laboratory findings. In a case report, discontinuing vitamin A led to a reduction in elevated serum retinol levels and the resolution of associated symptoms, including desquamation. Thrombocytopenia and elevated liver enzymes were likely secondary to hypervitaminosis A, highlighting the importance of monitoring and adjusting vitamin A intake to avoid toxicity.[29]
Enhancing Healthcare Team Outcomes
Interprofessional healthcare team members, including clinicians, nurses, dietitians, and pharmacists, should be aware that empirical dispensing of vitamin A is not recommended. Unless a deficiency is diagnosed, patients should not be encouraged to take excessive amounts of this vitamin, as it is known to cause toxicity. Instead, patients should be advised to maintain a healthy diet rather than relying on supplements. Available data suggest that consuming vitamin A supplements without a diagnosed deficiency may not offer health benefits.[30]
Pediatricians are critical in diagnosing vitamin A deficiency and ensuring appropriate supplementation or treatment for affected children. Nutritionists assess dietary intake, recommend necessary adjustments, and guide safe vitamin A supplementation to prevent both deficiency and toxicity. Ophthalmologists diagnose and manage ocular manifestations of vitamin A deficiency, such as night blindness and Bitot spots, while also monitoring for potential toxicity symptoms. Public health experts design and implement community-wide strategies to address vitamin A deficiency and prevent excessive intake, particularly in vulnerable populations.
Nurses play a vital role in monitoring for signs of vitamin A deficiency or toxicity, educating patients on safe supplementation, and assisting with administration. Pharmacists ensure proper dispensing of vitamin A supplements, provide counseling on safe usage, and alert patients about the risks of overdose. Neurologists assess and manage neurological manifestations linked to vitamin A toxicity. An interprofessional team approach and effective communication among healthcare providers are essential to reducing potential adverse effects and improving patient outcomes related to vitamin A.
References
Moise AR, Noy N, Palczewski K, Blaner WS. Delivery of retinoid-based therapies to target tissues. Biochemistry. 2007 Apr 17:46(15):4449-58 [PubMed PMID: 17378589]
Level 3 (low-level) evidenceWolbach SB, Howe PR. TISSUE CHANGES FOLLOWING DEPRIVATION OF FAT-SOLUBLE A VITAMIN. The Journal of experimental medicine. 1925 Nov 30:42(6):753-77 [PubMed PMID: 19869087]
Huiming Y, Chaomin W, Meng M. Vitamin A for treating measles in children. The Cochrane database of systematic reviews. 2005 Oct 19:2005(4):CD001479 [PubMed PMID: 16235283]
Level 1 (high-level) evidenceSahile Z, Yilma D, Tezera R, Bezu T, Haileselassie W, Seifu B, Ali JH. Prevalence of Vitamin A Deficiency among Preschool Children in Ethiopia: A Systematic Review and Meta-Analysis. BioMed research international. 2020:2020():8032894. doi: 10.1155/2020/8032894. Epub 2020 Feb 27 [PubMed PMID: 32258145]
Level 1 (high-level) evidenceDawson MI. The importance of vitamin A in nutrition. Current pharmaceutical design. 2000 Feb:6(3):311-25 [PubMed PMID: 10637381]
Level 3 (low-level) evidenceZhou Y, Wu Q, Wang F, Chen S, Zhang Y, Wang W, Huang C, Liu K, Chen B. Association of variant vitamin statuses and tuberculosis development: a systematic review and meta-analysis. Annals of medicine. 2024 Dec:56(1):2396566. doi: 10.1080/07853890.2024.2396566. Epub 2024 Sep 2 [PubMed PMID: 39221709]
Level 1 (high-level) evidenceGunzinger JM, Muth DR, Hanson JVM, Al-Sheikh M, Fasler K, Barthelmes D, Zweifel SA. Vitamin A deficiency retinopathy related to medical interventions in a Swiss cohort: a case series. Swiss medical weekly. 2023 Nov 1:153():40097. doi: 10.57187/smw.2023.40097. Epub 2023 Nov 1 [PubMed PMID: 37921090]
Level 2 (mid-level) evidenceMarley A, Smith SC, Ahmed R, Nightingale P, Cooper SC. Vitamin A deficiency: experience from a tertiary referral UK hospital; not just a low- and middle-income country issue. Public health nutrition. 2021 Dec:24(18):6466-6471. doi: 10.1017/S1368980021003347. Epub 2021 Aug 12 [PubMed PMID: 34380588]
Rakshasbhuvankar A, Patole S, Simmer K, Pillow JJ. Enteral vitamin A for reducing severity of bronchopulmonary dysplasia in extremely preterm infants: a randomised controlled trial. BMC pediatrics. 2017 Dec 16:17(1):204. doi: 10.1186/s12887-017-0958-x. Epub 2017 Dec 16 [PubMed PMID: 29246130]
Level 1 (high-level) evidenceYuanyuan G, Wang D, Hao Y, Guan Y, Bu H, Wang H. Study on serum vitamin A level in patients with type 1 diabetes: A systematic review and meta-analysis. Medicine. 2024 Oct 11:103(41):e40029. doi: 10.1097/MD.0000000000040029. Epub [PubMed PMID: 39465858]
Level 1 (high-level) evidenceAmescua G, Ahmad S, Cheung AY, Choi DS, Jhanji V, Lin A, Mian SI, Rhee MK, Viriya ET, Mah FS, Varu DM, American Academy of Ophthalmology Preferred Practice Pattern Cornea/External Disease Panel. Dry Eye Syndrome Preferred Practice Pattern®. Ophthalmology. 2024 Apr:131(4):P1-P49. doi: 10.1016/j.ophtha.2023.12.041. Epub 2024 Feb 12 [PubMed PMID: 38349301]
Kilby K, Mathias H, Boisvenue L, Heisler C, Jones JL. Micronutrient Absorption and Related Outcomes in People with Inflammatory Bowel Disease: A Review. Nutrients. 2019 Jun 20:11(6):. doi: 10.3390/nu11061388. Epub 2019 Jun 20 [PubMed PMID: 31226828]
Meléndez-Martínez AJ. An Overview of Carotenoids, Apocarotenoids, and Vitamin A in Agro-Food, Nutrition, Health, and Disease. Molecular nutrition & food research. 2019 Aug:63(15):e1801045. doi: 10.1002/mnfr.201801045. Epub 2019 Jun 26 [PubMed PMID: 31189216]
Level 3 (low-level) evidenceElmadfa I, Meyer AL. The Role of the Status of Selected Micronutrients in Shaping the Immune Function. Endocrine, metabolic & immune disorders drug targets. 2019:19(8):1100-1115. doi: 10.2174/1871530319666190529101816. Epub [PubMed PMID: 31142256]
Lerner UH. Vitamin A - discovery, metabolism, receptor signaling and effects on bone mass and fracture susceptibility. Frontiers in endocrinology. 2024:15():1298851. doi: 10.3389/fendo.2024.1298851. Epub 2024 Apr 22 [PubMed PMID: 38711977]
Schmitt C, Domangé B, Torrents R, de Haro L, Simon N. Hypervitaminosis A Following the Ingestion of Fish Liver: Report on 3 Cases from the Poison Control Center in Marseille. Wilderness & environmental medicine. 2020 Dec:31(4):454-456. doi: 10.1016/j.wem.2020.06.003. Epub 2020 Aug 27 [PubMed PMID: 32861618]
Level 3 (low-level) evidenceIshaq MU, Kunwar D, Qadeer A, Komel A, Safi A, Malik A, Malik L, Akbar A. Effect of vitamin A on maternal, fetal, and neonatal outcomes: An overview of deficiency, excessive intake, and intake recommendations. Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition. 2024 Apr:39(2):373-384. doi: 10.1002/ncp.11096. Epub 2023 Nov 29 [PubMed PMID: 38030585]
Level 3 (low-level) evidenceBastos Maia S, Rolland Souza AS, Costa Caminha MF, Lins da Silva S, Callou Cruz RSBL, Carvalho Dos Santos C, Batista Filho M. Vitamin A and Pregnancy: A Narrative Review. Nutrients. 2019 Mar 22:11(3):. doi: 10.3390/nu11030681. Epub 2019 Mar 22 [PubMed PMID: 30909386]
Level 3 (low-level) evidenceGannon BM, Jones C, Mehta S. Vitamin A Requirements in Pregnancy and Lactation. Current developments in nutrition. 2020 Oct:4(10):nzaa142. doi: 10.1093/cdn/nzaa142. Epub 2020 Aug 24 [PubMed PMID: 32999954]
Imdad A, Mayo-Wilson E, Haykal MR, Regan A, Sidhu J, Smith A, Bhutta ZA. Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age. The Cochrane database of systematic reviews. 2022 Mar 16:3(3):CD008524. doi: 10.1002/14651858.CD008524.pub4. Epub 2022 Mar 16 [PubMed PMID: 35294044]
Level 1 (high-level) evidenceChallem JJ. Teratogenicity of high vitamin A intake. The New England journal of medicine. 1996 May 2:334(18):1196-7 [PubMed PMID: 8602194]
Level 3 (low-level) evidenceHeck AM, Yanovski JA, Calis KA. Orlistat, a new lipase inhibitor for the management of obesity. Pharmacotherapy. 2000 Mar:20(3):270-9 [PubMed PMID: 10730683]
Park B, Kim J. Oral Contraceptive Use, Micronutrient Deficiency, and Obesity among Premenopausal Females in Korea: The Necessity of Dietary Supplements and Food Intake Improvement. PloS one. 2016:11(6):e0158177. doi: 10.1371/journal.pone.0158177. Epub 2016 Jun 27 [PubMed PMID: 27348598]
Paulus WE. [Pharmacotherapy in pregnancy]. Therapeutische Umschau. Revue therapeutique. 1999 Oct:56(10):602-7 [PubMed PMID: 10549233]
O'Connor EA, Evans CV, Ivlev I, Rushkin MC, Thomas RG, Martin A, Lin JS. Vitamin and Mineral Supplements for the Primary Prevention of Cardiovascular Disease and Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2022 Jun 21:327(23):2334-2347. doi: 10.1001/jama.2021.15650. Epub [PubMed PMID: 35727272]
Level 1 (high-level) evidenceLibien J, Kupersmith MJ, Blaner W, McDermott MP, Gao S, Liu Y, Corbett J, Wall M, NORDIC Idiopathic Intracranial Hypertension Study Group. Role of vitamin A metabolism in IIH: Results from the idiopathic intracranial hypertension treatment trial. Journal of the neurological sciences. 2017 Jan 15:372():78-84. doi: 10.1016/j.jns.2016.11.014. Epub 2016 Nov 10 [PubMed PMID: 28017254]
Greaves RF, Woollard GA, Hoad KE, Walmsley TA, Johnson LA, Briscoe S, Koetsier S, Harrower T, Gill JP. Laboratory medicine best practice guideline: vitamins a, e and the carotenoids in blood. The Clinical biochemist. Reviews. 2014 May:35(2):81-113 [PubMed PMID: 25210208]
Level 1 (high-level) evidence. Retinoids. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. 2012:(): [PubMed PMID: 31643883]
Sammartano A, Bertoncini L, Barbuti A, Ippolito L. A suspected hypervitaminosis A. Acta bio-medica : Atenei Parmensis. 2023 Jun 14:94(3):e2023098. doi: 10.23750/abm.v94i3.14041. Epub 2023 Jun 14 [PubMed PMID: 37326274]
Rathmann AM, Seifert R. Vitamin A-containing dietary supplements from German and US online pharmacies: market and risk assessment. Naunyn-Schmiedeberg's archives of pharmacology. 2024 Sep:397(9):6803-6820. doi: 10.1007/s00210-024-03050-6. Epub 2024 Mar 28 [PubMed PMID: 38546747]